Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy-Reference-Cited by-同舟云学术

Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy

Published:2023-04-26 Issue:4 Volume:27 Page:537-550
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Fitzgerald Sandra,Blenkiron Cherie,Stephens Rosalie,Mathy Jon A.,Somers-Edgar Tiffany,Rolfe Gill,Martin Richard,Jackson Christopher,Eccles Michael,Robb Tamsin,Rodger Euan,Lawrence Ben,Guilford Parry,Lasham Annette,Print Cristin G.^ORCID

Funder

Healthier Lives National Science Challenge, NZ

Cancer Research Trust, NZ

Maurice Wilkins Centre for Molecular Biodiscovery

William Staunton Scholarship Fund

University of Auckland School of Medicine Foundation

University of Auckland

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-023-00651-4.pdf

Reference97 articles.

1. Akbani R, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681–96.

2. Mann MB, et al. Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma. Nat Genet. 2015;47(5):486–95.

3. Trevarton A, et al. MelanomaDB: A web tool for integrative analysis of melanoma genomic information to identify disease-associated molecular pathways. Front Oncol. 2013;3:184.

4. Gandini S, et al. Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis. Crit Rev Oncol Hematol. 2021;157: 103187.

5. Feng SN, et al. The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis. Transl Oncol. 2021;14(6): 101072.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of multiple activating NRAS variants under BRAF/MEK-inhibitor therapy in BRAF positive malignant melanoma using liquid biopsy;JAAD Case Reports;2024-10

2. Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions;Cancers;2024-03-18